Neoplasm Metastasis  >>  oxaliplatin  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00885950: Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants

Completed
N/A
80
Europe
Maastricht University Medical Center
Sinusoidal Obstruction Syndrome, Colorectal Liver Metastases
12/09
06/10
NCT01399190: An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer

Completed
N/A
68
Europe
Bevacizumab, Avastin®, Capecitabine, Xeloda®, Oxaliplatin, Eloxatin™
Hoffmann-La Roche
Colorectal Cancer
02/14
02/14
SIRFLOX, NCT00724503: FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer

Checkmark ASCO-GI 2016
Jan 2016 - Jan 2016: ASCO-GI 2016
Checkmark SIRFLOX
Nov 2015 - Nov 2015: SIRFLOX
Checkmark
More
Completed
N/A
530
US, Europe, RoW
SIR-Spheres yttrium-90 microspheres, mFOLFOX6m + SIRT, SIR-Spheres Y-90 microspheres, Systemic chemotherapy (FOLFOX), mFOLFOX6
Sirtex Medical
Colorectal Cancer, Colorectal Carcinoma, Liver Metastases
05/15
05/15
ATOM ES, NCT01834014: Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

Completed
N/A
110
Japan
Bevacizumab, Avastin, Cetuximab, Erbitux, L-OHP, Oxaliplatin, l-LV, Levofolinate, 5-FU, Fluorouracil
EPS Corporation
Liver Metastasis, Colorectal Cancer
03/17
03/17
NCT01163305: PET-CT and Circulating Tumor Cells in Colorectal Cancer

Completed
N/A
84
RoW
Chemotherapy
Chinese University of Hong Kong
Colorectal Cancer, Metastasis
04/17
04/17

Download Options